 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Top-quality peptide freeze-dried powder Retatrutide 10mg

Top-quality peptide freeze-dried powder Retatrutide 10mg buy - large image1

Top-quality peptide freeze-dried powder Retatrutide 10mg buy - image1

Top-quality peptide freeze-dried powder Retatrutide 10mg buy - image2

Top-quality peptide freeze-dried powder Retatrutide 10mg buy - image3

Top-quality peptide freeze-dried powder Retatrutide 10mg buy - image4

Top-quality peptide freeze-dried powder Retatrutide 10mg

Unit Price:

$67-77/MT EXW

Get Latest Price 

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Packaging:

10 vials/box

Price valid (until):

2027-09-01

Contact Supplier

 Chat Now

TONGQI FUTYRE LIMITED

Company Type:

Trader

Location:

Hongkong, China

Qualification:

Main Products:

Retatrutide

 Visit Store

Product Description
Seller Information

Description

Product Detail

Name：Iris

Email：Xb20050416@gmail.com

WhatsApp：+852 6391 4517

Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C.

Name Retatrutide

CAS NO. 2381089-83-2

Specification 10mg

Peptide purity 99%

Packing & Delivering

We use dedicated transport routes, ensuring safety and reliability.

Contact information

Basic Info

Product Name:
peptide,reta,Retatrutide 10mg

Categories:
Bulk Drug Intermediates

Research

Class:
Triple agonist — GCGR, GIPR, GLP-1R

Status:
Investigational (Phase 3)

Mechanism:
Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):
5.79 nM

EC50 (Mouse GIPR):
0.191 nM

EC50 (Mouse GLP1R):
0.794 nM

EC50 (Mouse GCGR):
2.32 nM

EC50 (Human GLP1R):
0.775 nM

EC50 (Human GIPR):
0.0643 nM

Source:
Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:
NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:
CHEMBL5095485

DrugBank:
DB18993

KEGG DRUG:
D12430

PubChem:
PubChem

Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Seller Information

Business Type:
Trader

Main Products:
Retatrutide

Location:
B27 SHING LEE COMM BLDG 8 WING KUT ST CENTRAL HONG KONG

Year of Establishment:
2026
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Top-quality peptide freeze-dried powder Retatrutide 10mg

Product Description

Seller Information

Related Products

Related Searches

More from this Seller

Name	Retatrutide
CAS NO.	2381089-83-2
Specification	10mg
Peptide purity	99%